scispace - formally typeset
H

Hüseyin Büyükbayram

Researcher at Dicle University

Publications -  126
Citations -  1302

Hüseyin Büyükbayram is an academic researcher from Dicle University. The author has contributed to research in topics: Reperfusion injury & Lymphoma. The author has an hindex of 20, co-authored 125 publications receiving 1201 citations. Previous affiliations of Hüseyin Büyükbayram include Zonguldak Karaelmas University.

Papers
More filters
Journal ArticleDOI

Spontaneous rupture of malarial spleen: two case reports and review of literature.

TL;DR: Spontaneous rupture of malarial spleen is rare, and 15 episodes of spontaneous rupture of the spleen in the English language literature published since 1961 are identified, which is a major medical problem that is becoming increasingly important to surgeons worldwide.
Journal ArticleDOI

Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats

TL;DR: It is suggested that resveratrol has protective effects against hepatic I/R injury, and is a potential therapeutic drug for ischemia reperfusion-related liver injury.
Journal ArticleDOI

Increased Caspase-3 Immunoreactivity of Erythrocytes in STZ Diabetic Rats

TL;DR: In this experimental study, it is presented that the majority of erythrocytes shows caspase-3 immunoreactivity in streptozocin- (STZ)-induced diabetic rats and this may start a debate that eryptosis could have a role in the diabetic complications.
Journal Article

Mast cells count and serum cytokine levels in patients with irritable bowel syndrome.

TL;DR: Histopathologic and laboratory data demonstrate low-grade mucosal inflammation in a subset of patients with IBS, suggesting mast cells and cytokines may be related to the pathophysiologic mechanism of IBS.
Journal ArticleDOI

The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats

TL;DR: The most significant neurological functional and histopathological improvements were observed after systemical administration of MPSS + rHu-EPO 3,000 U and rHu- EPO3,000-U group, which provides the most improved neurological Functional and Histopathological recovery.